OC
PRCT icon

Oppenheimer & Co’s Procept Biorobotics PRCT Stock Holding History

Oppenheimer & Co’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,503
Closed -$842K – 1630
2024
Q3 		$842K Buy
+10,503
New +$746K 0.01% 850

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Oppenheimer & Co's PRCT Position: Q4 2024 in Review

Oppenheimer & Co sold out of Procept Biorobotics (PRCT) in Q4 2024, closing a stake of 10,503 shares — an estimated $842K sold.

Oppenheimer & Co first reported a position in PRCT in Q3 2024 and held it in 1 quarter. The position peaked at $842K in Q3 2024. 281 funds tracked by Wall St. Rank hold PRCT as of Q4 2024.

  • Oppenheimer & Co reported no remaining Procept Biorobotics position as of Q4 2024 after selling out during the quarter.
  • Oppenheimer & Co sold 10,503 Procept Biorobotics shares in Q4 2024, an estimated $842K.
  • Oppenheimer & Co first reported a position in Procept Biorobotics in Q3 2024 and held it in 1 quarter.
  • Oppenheimer & Co's Procept Biorobotics position peaked at $842K in Q3 2024.
  • 281 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2024.

Based on Oppenheimer & Co's 13F filing for Q4 2024, filed 5 Feb 2025.